Alzheimer's disease research, amyloid plaques, tau tangles, and cognitive decline
182 articles
Scientists developed mitoDREADD-Gs, a novel tool that restores cognitive function by enhancing mitochondrial activity in mouse models of dementia.
New review reveals promising tau-targeting therapies showing cognitive benefits and slowed brain pathology in Alzheimer's trials.
New precision medicine approach combines genetic risk factors with environmental exposures to predict and prevent dementia.
New research suggests people with APOE4 variants who eat more meat show slower cognitive decline and lower dementia risk.
New research identifies FTL1 protein as key driver of brain aging. Reducing it restored memory and neural connections in mice.
PEMFs repair mitochondrial damage and boost brain signaling pathways in stressed neurons, offering new therapeutic hope.
Groundbreaking research using 34,000 participants proves sarcopenia causally increases cognitive impairment risk through genetic analysis.
New research reveals how context-dependent protein interactions regulate TDP-43 dysfunction in ALS and frontotemporal dementia.
Researchers decode how brain cells communicate in vascular dementia, revealing potential therapeutic targets for this common form of dementia.
New study identifies KCTD20 gene suppression as a potential therapeutic target for clearing harmful tau proteins in neurodegenerative diseases.
New research reveals how the longevity protein Klotho may protect against Alzheimer's disease, with Mediterranean diet potentially boosting levels.
Comprehensive review proposes integrated dementia care model for India, addressing biological pathways and lifestyle interventions.
